SMTL ID : 9bhi.1

Crystal structure of the MerTK kinase domain with SA4488

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.07 Å

Oligo State

monomer

Ligands

1 x 01: (5P)-2-amino-5-(1-methyl-1H-pyrazol-4-yl)-N-{(1R,2S)-2-[(4'-{2-[4-(2-oxoethyl)piperazin-1-yl]propan-2-yl}[1,1'-biphenyl]-4-yl)methoxy]cyclopentyl}pyridine-3-carboxamide

01.1: 29 residues within 4Å: Chain A: L.44, V.52, A.68, K.70, F.85, E.88, A.89, M.92, I.101, L.103, V.120, L.122, P.123, F.124, M.125, G.128, R.173, R.178, N.179, M.181, A.191, D.192, F.193, G.194, L.195, S.196, D.203, Y.204, Y.205 19 PLIP interactions: 19 interactions with chain A Hydrophobic interactions: A:L.44, A:V.52, A:V.52, A:A.68, A:K.70, A:F.85, A:E.88, A:L.103, A:V.120, A:L.122, A:L.122, A:F.193, A:F.193 Hydrogen bonds: A:P.123, A:M.125, A:R.173, A:D.192 Salt bridges: A:E.88, A:E.88

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 2 residues within 4Å: Chain A: K.271, Q.272 Ligand excluded by PLIP CL.3: 4 residues within 4Å: Chain A: Y.252, P.253, L.270, K.271 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yu, Y. et al., Discovery of A-910, a Highly Potent and Orally Bioavailable Dual MerTK/Axl-Selective Tyrosine Kinase Inhibitor. J.Med.Chem. (2024)

Release Date

2024-10-09

Peptides

Mer tyrosine kinase domain: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mer tyrosine kinase domain

Related Entries With Identical Sequence